Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
12th week of 2021 patent applcation highlights part 10
Patent application number
Title
Published
20210085705
METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE
2021-03-25
20210085706
MICRORNA AND USES THEREOF IN PREVENTION AND/OR TREATMENT OF FIBROPLASIA MEDICAL SIGN AND/OR SYNDROME
2021-03-25
20210085707
IMPROVED BCL11A MICRORNAS FOR TREATING HEMOGLOBINOPATHIES
2021-03-25
20210085708
Novel Hydrogel
2021-03-25
20210085709
HIGH ELASTICITY HYALURONAN COMPOSITIONS AND METHODS OF USE THEREOF
2021-03-25
20210085710
A NEW USE OF THE POLOXAMER AS A PHARMACOLOGICALLY ACTIVE SUBSTANCE
2021-03-25
20210085711
USE OF FERRIC CITRATE IN PREVENTION AND/OR TREATMENT OF IRON-DEFICIENCY ANEMIA IN HYPERMENORRHEA PATIENT AND/OR PATIENT SUFFERING FROM HYPERMENORRHEA-ASSOCIATED GYNECOLOGIC DISEASE
2021-03-25
20210085712
FUNCTIONAL FOOD
2021-03-25
20210085713
COMPOSITIONS AND METHODS FOR TREATING STROKE
2021-03-25
20210085714
EXPANSION OF NK AND DC CELLS IN VIVO MEDIATING IMMUNE RESPONSE
2021-03-25
20210085715
T CELL DISEASE TREATMENT TARGETING TAG-72
2021-03-25
20210085716
ANTIGEN BINDING MOLECULES FOR SMALL CELL LUNG CANCER
2021-03-25
20210085717
CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLS
2021-03-25
20210085718
MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY
2021-03-25
20210085719
BISPECIFIC CAR T-CELLS FOR SOLID TUMOR TARGETING
2021-03-25
20210085720
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TET2 ENGINEERED T CELL THERAPY
2021-03-25
20210085721
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A CD8 ENGINEERED T CELL THERAPY
2021-03-25
20210085722
DOUBLE GENE-MODIFIED STEM CELL AND USE THEREOF
2021-03-25
20210085723
METHOD OF TREATING GRAFT VERSUS HOST DISEASE
2021-03-25
20210085724
CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER
2021-03-25
20210085725
MESENCHYMAL-LIKE STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS, METHODS AND USES THEREOF
2021-03-25
20210085726
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CELL PROLIFERATIVE DISEASE COMPRISING MIXTURE OF FEATHER OF BIRDS AND SCALE OF FISH AS AN ACTIVE INGREDIENT
2021-03-25
20210085727
PREPARATION AND APPLICATION OF GRAIN WORM FOR TREATING DIABETES
2021-03-25
20210085728
COMPOSITIONS COMPRISING BACTERIAL STRAINS
2021-03-25
20210085729
FOOD, COSMETIC AND PHARMACEUTICAL FORMULATION WITH AN IMMUNOMODULATORY AND PROTECTIVE ANTI-VIRAL EFFECT
2021-03-25
20210085730
USE OF BUTYRlBACTER INTESTINI IN PREVENTING AND/OR TREATING INFLAMMATION-RELATED DISEASES
2021-03-25
20210085731
A NOVEL LACTIC ACID BACTERIA AND ITS APPLICATIONS
2021-03-25
20210085732
METHOD AND COMPOSITION FOR PRODUCTION OF A PHYTONUTRIENT IN A MICROBIOME
2021-03-25
20210085733
NOVEL AEROMONAS HYDROPHILA BACTERIOPHAGE AER-HYP-3 AND USE THEREOF FOR INHIBITING GROWTH OF AEROMONAS HYDROPHILA BACTERIA
2021-03-25
20210085734
METHODS OF TREATING BLADDER CANCER
2021-03-25
20210085735
ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
2021-03-25
20210085736
IMMUNO-ONCOLYTIC MODIFIED VACCINIA TIAN TAN VIRUS AND METHODS OF TREATING CANCER
2021-03-25
20210085737
Probiotic Beverage Containing Living Mycelium and Method of Production
2021-03-25
20210085738
TOPICAL COMPOSITIONS COMPRISING EXTRACT OF CORIOLUS VERSICOLOR FOR AUTOIMMUNITY ENHANCEMENT
2021-03-25
20210085739
ANTIPLATELET ACTIVITY OF THE ACANTHUS MOLLIS SEEDS' TOTAL EXTRACT AND ITS CONSTITUENTS
2021-03-25
20210085740
ORAL USE OF CORIANDER SEED OIL FOR A SOOTHING EFFECT ON REACTIVE SKIN
2021-03-25
20210085741
Fagopyrum Nutraceutical Compositions
2021-03-25
20210085742
FRUIT EXTRACT AND USES THEREOF
2021-03-25
20210085743
SARRACENIA-BASED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
2021-03-25
20210085744
EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA
2021-03-25
20210085745
METHODS OF IDENTIFYING RISK OF BEVACIZUMAB-INDUCED PROTEINURIA AND HYPERTENSION
2021-03-25
20210085746
METHOD FOR PREVENTING OR TREATING HANGOVER SYMPTOM(S) ASSOCIATED WITH CONSUMPTION OF ALCOHOLIC BEVERAGE(S)
2021-03-25
20210085747
PHARMACEUTICAL COMPOSITION COMPRISING THROMBOLYTIC PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE
2021-03-25
20210085748
Implantable medical device having a negatively-charged and antimicrobial surface
2021-03-25
20210085749
Therapeutic and Neuroprotective Peptides
2021-03-25
20210085750
PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
2021-03-25
20210085751
NOVEL COMPOSITION
2021-03-25
20210085752
ANTI-PATHOGEN COMPOSITION AND METHODS OF USE THEREOF
2021-03-25
20210085753
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS
2021-03-25
20210085754
MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG
2021-03-25
20210085755
GLP-1 COMPOSITIONS AND USES THEREOF
2021-03-25
20210085756
SUPERACTIVE MUTANT THYMIDINE KINASE FOR USE IN CANCER THERAPY
2021-03-25
20210085757
Anti-Inflammatory Peptides and Composition Comprising the Same
2021-03-25
20210085758
IDENTIFICATION OF LYSINS AND DERIVATIVES THEREOF WITH BACTERICIDAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA
2021-03-25
20210085759
METHODS TO TREAT POMPE DISEASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS
2021-03-25
20210085760
ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
2021-03-25
20210085761
Compositions and Methods for Treating Celiac Sprue Disease
2021-03-25
20210085762
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
2021-03-25
20210085763
Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and Disorders
2021-03-25
20210085764
DRY POWDER FORMULATIONS OF ALPHA-1 ANTITRYPSIN
2021-03-25
20210085765
METHODS AND COMPOSITIONS FOR PRE-EMPTIVE TREATMENT OF GRAFT VERSUS HOST DISEASE
2021-03-25
20210085766
AMH-INH-GNIH TRI-EXPRESSION GENE VACCINE OF IMPROVING FECUNDITY OF ANIMALS, PREPARATION METHOD AND APPLICATION
2021-03-25
20210085767
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
2021-03-25
20210085768
Fusion Comprising A Cell Penetrating Peptide, A Multi Epitope And A TLR Peptide Agonist For Treatment Of Cancer
2021-03-25
20210085769
CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR TUMOR CELLS
2021-03-25
20210085770
NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
2021-03-25
20210085771
METHOD FOR INDUCING A TOLEROGENIC IMMUNE RESPONSE
2021-03-25
20210085772
Bioconjugates Made From Recombinant N-Glycosylated Proteins From Procaryotic Cells
2021-03-25
20210085773
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
2021-03-25
20210085774
VACCINES WITH ENHANCED IMMUNOGENICITY, LOW ALLERGENICITY AND REACTOGENICITY
2021-03-25
20210085775
METHODS AND COMPOSITION FOR PREVENTING AND/OR TREATING CANCER
2021-03-25
20210085776
DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L
2021-03-25
20210085777
CANCER IMMUNOTHERAPY USING VIRUS PARTICLES
2021-03-25
20210085778
PARENTERAL NOROVIRUS VACCINE FORMULATIONS
2021-03-25
20210085779
PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY
2021-03-25
20210085780
Immunogenic Human Rhinovirus (HRV) Composition
2021-03-25
20210085781
NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
2021-03-25
20210085782
VETERINARY PRODUCT
2021-03-25
20210085783
PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
2021-03-25
20210085784
COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER
2021-03-25
20210085785
TREATING CANCER BY BLOCKING THE INTERACTION OF VISTA AND ITS BINDING PARTNER
2021-03-25
20210085786
COMBINATION TREATMENT OF CHEMORESISTANT CANCERS
2021-03-25
20210085787
METHOD FOR INDUCING TUMOR REGRESSION
2021-03-25
20210085788
METHODS FOR PHOTODYNAMIC THERAPY
2021-03-25
20210085789
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
2021-03-25
20210085790
IR700 Nanocompositions for Cardiac Therapies and Applications
2021-03-25
20210085791
METHODS FOR PROTECTING AND TREATING TRAUMATIC BRAIN INJURY, CONCUSSION AND BRAIN INFLAMMATION WITH INTRANASAL INSULIN
2021-03-25
20210085792
Liquid Protein Formulations Containing Viscosity-Lowering Agents
2021-03-25
20210085793
BRANCHED OLIGONUCLEOTIDES
2021-03-25
20210085794
INJECTABLE PREPARATION
2021-03-25
20210085795
CROSS-LINKED MALTODEXTRINS FOR THE ORAL DELIVERY OF BIOLOGICAL ACTIVES
2021-03-25
20210085796
ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME
2021-03-25
20210085797
TOPICAL DELIVERY OF THERAPEUTIC AGENTS USING CELL-PENETRATING PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES
2021-03-25
20210085798
IMMUNITY LINKER MOLECULES AND THEIR USE IN THE TREATMENT OF INFECTIOUS DISEASES
2021-03-25
20210085799
ONE-POT PROCESS FOR PREPARING INTERMEDIATE OF ANTIBODY-DRUG CONJUGATE
2021-03-25
20210085800
CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIES
2021-03-25
20210085801
AMPHIPHILIC BLOCK COPOLYMERS, MICELLES, AND METHODS FOR TREATING OR PREVENTING HEART FAILURE
2021-03-25
20210085802
NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEM
2021-03-25
20210085803
METHOD FOR OPENING TIGHT JUNCTIONS
2021-03-25
20210085804
NOVEL THERAPEUTICAL TOOLS AND METHODS FOR TREATING BLINDNESS BY TARGETING PHOTORECEPTORS
2021-03-25